HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

LncSNHG3 promotes hepatocellular carcinoma epithelial mesenchymal transition progression through the miR-152-3p/JAK1 pathway.

AbstractBACKGROUND:
The dysregulation of LncRNAs is related to the malignant progression of many cancers.
OBJECTIVE:
The study aimed to investigate the expression and the biological role of LncSNHG3 in hepatocellular carcinoma (HCC).
METHODS:
The TCGA data of the LncSNHG3 in HCC were analyzed. The expression in HCC cell lines was detected by qRT-PCR. Proliferation, migration, and invasion of HepG2 and Huh7 were examined by cell counting kit-8, colony formation, transwell assays, and wound healing assays. At the same time, the interactions among LncSNHG3, miR-152-3p, and JAK1 were confirmed by dual-luciferase reporter assay, RNA immunoprecipitation, subcellular distribution. Xenograft tumor-bearing mice models were used to measure the effect of LncSNHG3 on the growth of HCC in vivo. The apoptosis and epithelial mesenchymal transition (EMT)-associated proteins were checked by WB and IHC.
RESULTS:
LncSNHG3 was overexpressed in HCC tissues and cell lines. In addition, it is correlated with the tumor stage and survival time of HCC patients. Down-regulated LncSNHG3 could significantly suppress the EMT progression of HCC in vivo and in vitro. LncSNHG3 could promote the JAK1 expression by sponging miR-152-3p.
CONCLUSIONS:
LncSNHG3 acted as an oncogene and promoted the EMT procession in HCC by binding miR-152-3p and promoting JAK1 expression. Predictably, LncSNHG3 was used as a potential marker and will be used as a novel therapy target for HCC in the future.
AuthorsHong Li, Yu Wu, Runmei Wang, Junmei Guo, Qin Yu, Lihe Zhang, Haiping Zhao, Hao Yang
JournalGenes & genomics (Genes Genomics) Vol. 44 Issue 1 Pg. 133-144 (Jan 2022) ISSN: 2092-9293 [Electronic] Korea (South)
PMID34778942 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021. The Genetics Society of Korea.
Chemical References
  • MIRN152 microRNA, human
  • MicroRNAs
  • RNA, Long Noncoding
  • JAK1 protein, human
  • Janus Kinase 1
Topics
  • Animals
  • Carcinoma, Hepatocellular (genetics, metabolism)
  • Cell Line, Tumor
  • Cell Movement (genetics)
  • Cell Proliferation (genetics)
  • Epithelial-Mesenchymal Transition (genetics)
  • Female
  • Gene Expression Regulation, Neoplastic
  • Gene Knockdown Techniques
  • Hep G2 Cells
  • Humans
  • Janus Kinase 1 (genetics, metabolism)
  • Kaplan-Meier Estimate
  • Liver Neoplasms (genetics, metabolism)
  • Male
  • Mice, Inbred BALB C
  • Mice, Nude
  • MicroRNAs (genetics)
  • Middle Aged
  • RNA, Long Noncoding (genetics)
  • Signal Transduction (genetics)
  • Xenograft Model Antitumor Assays (methods)
  • Mice

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: